{"schema_version":"secwatch.filing_event.v1","accession":"0002007919-24-000016","form_type":"8-K","ticker":"INBX","cik":"0002007919","company_name":"Inhibrx Biosciences, Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.401759+00:00","generated_at":"2026-06-01T04:11:19.735606+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Inhibrx posts updated corporate presentation; no material details in filing excerpt","bullets":["Company posted updated corporate presentation on its website on June 17, 2024.","No specific pipeline, financial, or milestone updates are visible from the filed excerpt.","Presentation attached as Exhibit 99.1; full content not included in this 8-K text.","Routine update without quantitative or event-driven disclosures for investors."],"urls":{"canonical":"https://secwatch.observer/filing/0002007919-24-000016","json":"https://secwatch.observer/filing/0002007919-24-000016.json","markdown":"https://secwatch.observer/filing/0002007919-24-000016.md","text":"https://secwatch.observer/filing/0002007919-24-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2007919/000200791924000016/0002007919-24-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2007919/000200791924000016/inhibrx-20240617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:11:19.735606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}